Protalix BioTherapeutics
PLX
#8963
Rank
C$0.26 B
Marketcap
C$3.28
Share price
0.65%
Change (1 day)
63.23%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): C$0.02393

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is C$0.02836. In 2024 the company made an earnings per share (EPS) of C$0.05672 a decrease over its 2023 EPS that were of C$0.17.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$0.02393-57.81%
2024C$0.05672-66.67%
2023C$0.17-138.71%
2022C-$0.44-50%
2021C-$0.88181.82%
2020C-$0.31-82.11%
2019C-$1.74-31.67%
2018C-$2.55-72.31%
2017C-$9.22124.14%
2016C-$4.11-147.54%
2015C$8.65-290.63%
2014C-$4.546.67%
2013C-$4.25130.77%
2012C-$1.84-69.77%
2011C-$6.1019.44%
2010C-$5.10-12.2%
2009C-$5.8136.67%
2008C-$4.25-37.5%
2007C-$6.8150%
2006C-$4.543.23%
2005C-$4.40138.46%
2004C-$1.84-74%
2003C-$7.09-0%
2002C-$7.09-50%
2001C-$14.18233.33%
2000C-$4.25-84.21%
1999C-$26.94-24%
1998C-$35.45-600%
1997C$7.09-16.67%
1996C$8.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.86 6,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$9.51 33,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C-$0.16-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$1.94 6,750.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel